Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder, Treatment-Resistant

Explore clinical trials studying Depressive Disorder, Treatment-Resistant. Study availability and eligibility vary by location and protocol.

39 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder, Treatment-Resistant trial results

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

NCT02153502

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +1 more
Locations
  • Birmingham, Alabama, United States
  • Birmingham, Alabama, United States
  • Bellflower, California, United States
  • Costa Mesa, California, United States
View all 32 locations
View Trial Details
Completed

A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression

NCT02493868

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +1 more
Locations
  • Birmingham, Alabama, United States
  • Little Rock, Arkansas, United States
  • Anaheim, California, United States
  • Garden Grove, California, United States
View all 155 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

NCT03434041

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +1 more
Locations
  • Atlanta Center for Medical Research Atlanta, Georgia, United States
  • Biomedical Research Foundation of Northwest Louisiana Shreveport, Louisiana, United States
  • CBH Health Gaithersburg, Maryland, United States
  • Adams Clinical Watertown, Massachusetts, United States
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression

NCT02422186

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +1 more
Locations
  • San Diego, California, United States
  • New Haven, Connecticut, United States
  • Miami, Florida, United States
  • Marietta, Georgia, United States
View all 69 locations
View Trial Details
Completed

Treatment Resistant Depression in America Latina

NCT03207282

Conditions
Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mental Disorders, +1 more
Locations
  • Fundacion para el Estudio y Tratamiento de las Enfermedades Mentales Buenos Aires, Argentina
  • Instituto DAMIC Córdoba, Argentina
  • Clinica Privada de Salud Mental Santa Teresa de Ávila La Plata, Argentina
  • CESASIN Mendoza, Argentina
View all 33 locations
View Trial Details

Related conditions